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oieties. AAbstract Biphenyls are an important intermediate in organic chemistry which constitutes the
structural moiety of a wide range of compounds with profound pharmacological activity. Being
a neutral molecule (due to absence of the active functional moiety on it), biphenyls are required
to be functionalized i.e. introduction of active group on it. Thus, the substituted biphenyls can
be used for synthesis or condensation of another active group with itself which are pharmacologi-
cally signiﬁcant thereby forming the compounds with altogether new activity. Initially, biphenyls
were widely used as intermediates in chemical synthesis and pesticides in the form of PCBs (poly-
chlorinated biphenyls). But with the emerging trends in the synthetic chemistry, a number of deriv-
atives are obtained which are of therapeutic signiﬁcance. This review is summarized to know about
synthesis of biphenyl and its derivatives as well as various biphenyl analogs that has potential to act
against number of disease and disorders.
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Biphenyls, as the name suggests, are two conjoined benzene
rings attached through their 1,10-positions. It is a white crystal
with characteristic pleasant smell (Pagan, 2012). Biphenyls are
important structural analog which are used considerably in
synthesis of various compounds. Earlier, biphenyl derivatives
were widely used as pesticides in the form of polychlorinated
biphenyls (PCBs) (see Fig. 1).
The biaryl axis is the central building block in a very large
number of various molecules such as natural and pharmaco-
logically active products, chiral reagents (Cram, 1988a,b), as
the source of chiral phases for chromatography, (Mikes and
Boshart, 1978) as inﬂexible ‘‘spacers’’ between two parts of a
molecule(Brandmeier et al., 1989a,b; Tabushi et al., 1984), as
the basis of liquid crystals (Yamamura et al., 1988, 1989)
and ﬂuorescent layers in OLEDs (Hohnholz et al., 2000). Dif-
ferent substituted biphenyls very often are used as suitable syn-
thetic intermediates for synthesis heteroaromatic and
polycyclic aromatic compounds (Yao et al., 2005). The key
step in such synthesis almost always is the coupling of two
matched aromatic parts of the target molecule. Another way
is the directed modiﬁcation of easily accessible biphenyls such
as, for example, 4, 40-biphenyldicarboxylic acid (Olkhovik
et al., 2008) (see Fig. 2).
Biphenyl is a neutral molecule and fairly non-reactive due
to lack of functional group. However, biphenyl participates
in many of the reactions that are typical for benzene, for exam-
ple, substitution reactions upon treatment with halogens in the
presence of a Lewis acid. Also, it is required to convert biphe-
nyls into the structural analogs containing the active groups in
order for it to be able to use for synthetic intermediate for the
production of a host of other organic compounds such as
emulsiﬁers, optical brighteners, crop protection products, plas-O
HO
O
OH
Figure 2 4,40-Biphenyldicarboxylic acid.
Figure 1 Biphenyl.
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this, it is important to consider the o,p-directing and/or m-
directing effect, especially when substitution at a speciﬁc posi-
tion is desired i.e. mono, di-, tri- or tetra- substitutions. It is
possible to acetylate the carboxylic part, also various other
biphenyl derivative synthesis are possible by carrying out the
amination, halogenation, sulphonation, alkylation, hydroxyl-
ation, metal complexation etc.
Biphenyl derivative syntheses have been widely carried out
and have yielded wide range of compounds with wide range of
activities such as: Antimicrobial, antifungal, anti proliferative,
anti diabetic, immunosuppressant, analgesic, anti inﬂamma-
tory etc. Number of parent structures and their derivatives
containing biphenyl moiety are synthesized and patented as
well, by the research scientists and chemists. The review will
start with general scheme for biphenyl synthesis, followed by
which the various synthetic schemes and also the methods to
synthesize various biphenyl derivatives have been summarized.
2. Synthesis of biphenyl
2.1 Biphenyl occurs naturally in coal tar, crude oil, and natural
gas and can be isolated from these sources via distillation. It
can also be synthesized synthetically by using a Grignard re-
agent such as phenylmagnesium bromide and reacting it with
bromobenzene, reacting ﬂuorobenzene with phenyl lithium
or reacting benzyne with phenyl lithium as follows (Metasyn-
thesis: The chemical theasaurus) (see Schemes 1–5).
2.2 Ullmann et al. (1904), discovered that heating iodoben-
zene with a copper powder catalyst leads to the formation of
biphenyl with high purity. Meanwhile, this reaction has be-
come a textbook case and it is widely used in synthetic chem-
istry due to its versatility in the association of substituted
phenyls to complex biphenyl derivatives.
The synthesis of biphenyl out of iodobenzene on copper
essentially consists of three steps: dissociation of iodobenzene
(C6H5I) to phenyl (C6H5) and iodine, diffusion of phenyl to
ﬁnd another phenyl as a reaction partner, and association to
form biphenyl (C12H10). The dissociation of iodobenzene by
thermal activation takes place at 180 K and biphenyl is
formed at 210 K for multilayer (Weiss et al., 1998) and
300 K for submonolayer iodobenzene on Cu(III) [Yang
et al., 1995; Xi and Bent, 1992]. Synthesis reported in reference
(Hla et al., 2000).
2.3 One of the well-recognized mechanisms for Ullmann
reaction (Hassan et al., 2001; Cepanec et al., 2007) involvesheir derivatives as synthetically and pharmacologically impor-
(2013), http://dx.doi.org/10.1016/j.arabjc.2013.07.035
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Scheme 1 Synthesis of biphenyl from ﬂuorobenzene and phenyl
lithium.
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Scheme 2 Synthesis of biphenyl from benzyne and phenyl
lithium.
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Scheme 3 Synthesis of biphenyl from iodobenzene.
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Biphenyl based phosphine: PPh2
Me
Scheme 4 Synthesis of biphenyl from bromobenzene.
Scheme 5 Synthesis of biphenyl from halobenzene using PTC
membrane.
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and Pd(II) species, respectively. The resulting Pd(IV) species
is very unstable and readily undergoes reductive elimination
to form Pd(II) species. A terminal reducing agent is required
to regenerate Pd(0) from Pd(II) in the terminal reduction step
and to complete the catalytic cycle. Several types of reductants
have been reported such as zinc powder (Kende et al., 1975),
tertiary amines (Hassan et al., 2001), hydrazine (Nakajima
et al., 1980), molecular hydrogen (Mukhopadhyay et al.,Please cite this article in press as: Jain, Z.J. et al., Biphenyls and t
tant aromatic structural moieties. Arabian Journal of Chemistry (1999) hydroquinone (Hennings et al., 1999). The main charac-
teristic of this mechanism is the change of palladium oxidation
state between zero, two and four.
2.4 In another typical reaction, the halobenzene and the
reducing agent were stirred in the presence of the catalyst
and a base to give biphenyl as the major product, together with
minor amounts of benzene (the byproduct due to the parallel
reduction reaction). No other products were observed
(Mukhopadhyay et al., 2001).
Conversions and product selectivities for various halobenz-
enes are shown in Table 1.
Carbon was the obvious support of choice due to its high
surface area and porosity, plus of course its high selectivity
as a support in previous Pd-catalyzed reductive coupling stud-
ies. Using carbon-supported PTC, an increased product selec-
tivity was observed (cf. Table 2, entries 1–3). When Na2CO3,
TBAB (Tetra-n-butyl ammonium bromide), and Pd were all
together supported on carbon, the rate and selectivity obtained
were very high under the reaction conditions (Table 2, entries 4
and 5), while depositing the formate on the carbon support to-
gether with the other components resulted in a low selectivity
to biphenyl due to an increase in reduction rate (Table 2, entry
6) (Mukhopadhyay et al., 2001).
2.5 Biphenyl can also be synthesized with a high selectivity
(88%) by the Pd-catalyzed dimerization of benzene in the pres-
ence of MoO2(acac)2 as a cocatalyst and O2 in acetic acid
(Okamoto and Yamaji, 2001). In continuing study, recently
investigated the effect of HPAs (heteropolyacids) of Keggin
type containing molybdenum such as H4SiW12-nMon, H15-
nPV12-nMonO40, and H3PW12-nMonO40 as a cocatalyst in
the Pd(OAc)2-catalyzed dimerization of benzene in the pres-
ence of O2 and acetic acid (Scheme 6) have been investigated
and found that HPAs of Keggin type containing molybdenum
act as an excellent cocatalyst to obtain biphenyl from benzene
in the Pd(OAc)2/HPA/O2/AcOH catalyst system (Okamoto
et al., 2002).
3. Synthesis of biphenyl derivatives as intermediates:
functionalization
As mentioned earlier it is necessary to functionalize the biphe-
nyl in order for it to be used as an intermediate for synthesis of
various compounds.
3.1Miyaura and Suzuki (1995) pioneered the use of arylbo-
ronates, more readily accessible than boronic acids, for the
cross-coupling reaction to afford biaryls (Ishiyama et al.,
1995). The use of this methodology was recently expanded
by developing a convenient one-pot protocol via aryl boro-
nates generated in situ (Zhu et al., 2003). This one pot proce-
dure allows coupling reactions between two aryl halides
without the need for boronic acids. In search for a scaleable
and economical synthesis of biphenyl aniline 1, amino and pro-
tected amino phenyl halides as boronate precursors in the one-
pot Suzuki coupling reaction was investigated. Although
amide aryl halides are known to cross couple with boronic
acids (Wolfe et al., 1999) there is very limited literature prece-
dent of amide aryl boronate in Suzuki coupling reactions.
The formamide derivatives 3(i-viii) were prepared in quan-
titative yields by treating appropriate anilines in formic acid/
acetic anhydride (Sheehan and Yang, 1958). One-pot Suzuki
coupling reaction between 3 and bromides 2 occurredheir derivatives as synthetically and pharmacologically impor-
2013), http://dx.doi.org/10.1016/j.arabjc.2013.07.035
Table 1 Coupling reactions with different starting material.a
Substrate Time (H) Conv. (%) Ar–Ar Ar–H
Chlorobenzene 8.5 100 83 17
Bromobenzene 8 100 92 8
Iodobenzene 6 100 93 7
a Reaction conditions: Substrate, 16 mmol; support 3 (Mukho-
padhayay et al., 2001), HCOONa, 19 mmol, temperature, 110 C;
agitation speed, 900 rpm; solvent, PhMe (total volume 50 mL).
Table 2 Coupling reaction with different starting material.a
Entry Support Time (h) Conv. (%) Select. (%) Ar–Ar
1b Support 1 6 100 34
2 Support 2 6.5 100 79
3 Support 2A 6 100 75
4 Support 3 8 100 92
5 Support 3A 7.5 100 89
6 Support 4 4 100 56
(Detailed procedures for the support preparation are given in ref-
erence Mukhopadhayay et al., 2001).
a Reaction conditions: Bromobenzene, 2.5 g (16 mmol), Na2CO3,
2.5 g (24 mmol), sodium formate, 1.3 g (19 mmol), solvent, PhMe
(total reaction volume 50 ml), temperature, 110 C.
b TBAB, 0.2 g (0.6 mmol).
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Scheme 7 Biphenyl formamide and biphenyl aniline synthesis
via one-pot Suzuki Coupling reaction.
4 Z.J. Jain et al.smoothly (Scheme 7), and the results are shown in Table 3. In
most cases, biphenyl4 was cleanly formed and isolated without
chromatography. Speciﬁcally, biphenyls4(i-viii) were obtained
cleanly in satisfactory yields (64–70%) after a simple tritur-
ation (entries i–v). Substituted biphenyl formanilides 4(vi–viii)
were also prepared in moderate yields (entries vi–viii). Except
for 4(vi) where a slower reaction was observed, hydrolysis of
the biphenyl formanilides 4 readily occurred under mild acidic
conditions to afford anilines 1 in near quantitative yields
(Scheme 7) (Hett et al., 1998) (see Tables 4 and 5).
3.2 Fluorinated biphenyl derivatives are fundamental build-
ing blocks in ﬂuorinated liquid crystals. The ﬂuoro-substitu-
tion of benzene rings in mesomorphic molecules may lead to
some changes in the melting point, viscosity, birefringence,
dielectric anisotropy and other physical properties. The liquid
crystalline materials containing monoﬂuoro-, diﬂuoro- or tri-
ﬂuoro-substituted phenyls (Goto and Kitanno, 1991; Nabor
et al., 1991; Hird et al., 1992) are the most prominent for appli-
cation in thin-ﬁlm transistor liquid crystal displays (TFT-
LCDS).
In order to efﬁciently synthesize some ﬂuorinated liquid
crystals in industry goal, a new, air-stable and highly active
P–O coordinated palladium-catalyst have been developed.
These complexes are ideal catalysts for the coupling of deacti-
vated aryl bromides as they are comparatively inexpensive,
very easily synthesized and can be used to give conversions
at low concentrations.Pd(OAc)2, Cocatalyst, O2
AcOH(.H2O), 130oC, 4hr
Scheme 6 Synthesis of b
Please cite this article in press as: Jain, Z.J. et al., Biphenyls and t
tant aromatic structural moieties. Arabian Journal of Chemistry3.3 In another study, it was shown that PdCl2-catalyzed
reductive coupling method can be employed to selectively syn-
thesize biphenyls from haloarenes, namely, 4-chlorotoluene in
the presence of an activated carbon supported phase-transfer
catalyst (PTC), a ligand (PPh3), and a reducing agent such
as zinc in anhydrous N,N-dimethylformamide (DMF). Similar
attempts have been made before to utilize PdCl2 as the cata-
lyst. However, only low reactivity was observed with chloroa-
renes, whereas bromo- and iodoarenes have reacted to give
coupling products (Lee et al., 2001). In fact, NiCl2 has been
employed (Kageyama et al., 1991, 1995) successfully as a cat-
alyst in similar coupling reactions; however, the need for extre-
mely toxic solvents (Kageyama et al., 1991, 1995) such as
pyridine or quinoline invalidates the utility of such processes.
Primarily, Zn was used as the reducing agent (Mukhopadhyay
et al., 2000a,b).
3.4 Tyrosinase. is a multifunctional copper-containing en-
zyme, that is, key in melanin biosynthesis, melanisation in ani-
mals, and browning in plants. Tyrosinase inhibitors can
therefore be clinically useful for the treatment of some derma-
tological disorders associated with melanin hyperpigmenta-
tion. In addition, these inhibitors are also known to be
useful in cosmetics for whitening and depigmentation after
sunburn (Chang, 2009; Kima and Uyamab, 2005). In the past
few decades, a number of polyphenol tyrosinase inhibitors
from both natural and synthetic sources, including ﬂavonoids,
stilbenes, and terpenoids, have been intensively investigated
(Okombi et al., 2006; Karioti et al., 2007; Khan et al.,
2006a,b; Shimizu et al., 2003). Fortuneanoside E is a new
biphenyl glycoside isolated from the fruit of Pyracantha for-
tuneana that has shown tyrosinase inhibitory activity (see
Fig. 3).
Generally, there are several methods for the construction of
biphenyls, including Stille coupling, the Gomberg–Bachmann
reaction, theUllmann reaction, and Suzuki–Miyaura cross-cou-OH OAc+ +
iphenyl from Benzene.
heir derivatives as synthetically and pharmacologically impor-
(2013), http://dx.doi.org/10.1016/j.arabjc.2013.07.035
Table 3 Synthesis of biphenyl formamide 4 and in turn biphenyl anilines 1 from iodo formamide 3 and aryl bromide 2 (Zhu et al.,
2008).
Entry Formamide 3R0= Aryl Bromide 2R= 4 (% Yield) 1 (% Yield)
i H COOMe
Me
Me
68 95
ii H
Ph
COOEt 65 96
iii H
Me
COOEt 64 92
iv H
H COOMe
H
67 98
v H H COOMe
H
70 90
vi Me COOMe
Me
Me
30 60
vii F COOMe
Me
Me
65 95
viii F H COOMe
H
65 90
Biphenyls and their derivatives as synthetically and pharmacologically important aromatic structural moieties 5pling. Considered the particularities of these methods and the
characteristics of the target compounds, Suzuki–Miyaura
cross-coupling was applied in the ﬁrst step. To ﬁnd the
optimal conditions, a model reaction was performed using
2-(benzyloxy)-4-bromobenzaldehyde and 3,4,5-trimethoxy-
phenylboronic acid under different conditions. This reaction
was found to be most efﬁcient in the presence of K2CO3 and
Pd(OAc)2 in DMF at 110 C and using these conditions, com-Please cite this article in press as: Jain, Z.J. et al., Biphenyls and t
tant aromatic structural moieties. Arabian Journal of Chemistry (pound 1 could be prepared in 72% yield (Bao et al., 2009). With
these optimized condition, biphenyls 1–19 were prepared from
various bromobenzenes (commercially available or prepared
by conventional methods) by Suzuki–Miyaura cross-coupling
with 3,4,5-trimethoxy-phenylboronic acid, resulting in yields
ranging from 68% to 92%. Methyl and benzyl ethers have been
widely used as stable protecting groups for hydroxyl groups in
organic synthesis.heir derivatives as synthetically and pharmacologically impor-
2013), http://dx.doi.org/10.1016/j.arabjc.2013.07.035
Table 4 Synthesis of ﬂuorinated biphenylsa (Guo et al., 2006).
R Br + B(OH)2
F
R
F
Cis-Pd(Ph2PCH2COO)2 (0.1% mol)
K3PO4.3H2O (3 Equiv.)
THF/H2O, (1:1), R.T
ENTRY R
B(OH)2
F TIME
b (h) YIELDc
1
C3H7 F B(OH)2
5 92
2
C3H7
F
F B(OH)2
5 91
3
C3H7
F
F B(OH)2
F
6 89
4
C5H11 F B(OH)2
5 94
5
C5H11
F
F B(OH)2
5 95
6
H3COC
F B(OH)2
6 99
7
H3C
F B(OH)2
6 88
8
H3CO
F B(OH)2
8 92
a Aryl bromide (1 mmol), ﬂuorinated phenylboronic acid (1.5 mmol), K3PO4.3H2O (3 mmol), Pd complex (0.001 mmol), THF= 2 ml. The
reaction was performed at room temperature, THF+H2O= 4 ml (1:1).
b Reaction time not optimized.
c Isolated yield was based on the aryl bromide.
6 Z.J. Jain et al.
Please cite this article in press as: Jain, Z.J. et al., Biphenyls and their derivatives as synthetically and pharmacologically impor-
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Table 5 Pd catalyzed reductive coupling of different substratesa (Qaﬁsheh et al., 2002).
2
R
R'
X
+ Zn
PdCl2, PTC/C
PPh3, DMF, 70oC, 6-12 hr
+ ZnX2
R
R
R'
R'
Haloarene R R0 X t (h) % Conversion % Selectivity (Ar–Ar)
1 CH3 H Cl 10 73 96
2 H CH3 Cl 6 33 100
3 CF3 H Cl 10 65 98
4 CHO H Cl 6 36 97
5 H H Cl 12 81 91
6 H H Br 12 84 98
a Reaction conditions: substrate, 7.9 mmol; PdCl2, 1.4 mmol; Zn, 19 mmol; PPh3, 1.9 mmol; carbon-supported TBAB, 0.5 g; solvent, 20 mL
of anhydrous DMF, temperature 70 C.
Table 6 Tyrosine inhibitory compounds 1–19 and 20–36 (Bao
et al., 2010).
Compounds R1 R2 R3 R4 R5
Compound I H OBn OH H H
1 H OBn CHO H H
2 H OH CHO H H
3 H OBn COOH H H
4 H OH COOH H H
5 H OH COOEt H H
6 H OBn CONHBn H H
7 H OH Me H H
8 H F H F H
9 F H F H H
10 H F F H H
11 F OMe H H H
12 OMe H H Ac H
13 OMe H H CHOHCH3 H
14 H OH H H H
15 H OBn H H H
16 Me H H H H
17 H H COOH H H
18 H H CONHBu H H
19 H H CONHBn H H
Fortuneonoside E H OH OGly H H
20 H OH CHO H H
21 H OH COOH H H
22 H OH COOEt H H
23 H OH CONHBn H H
24 H OH Me H H
25 H F H F H
Biphenyls and their derivatives as synthetically and pharmacologically important aromatic structural moieties 7A number of methods have been reported to perform cleav-
age of the methyl and benzyl groups in these ethers (Nishioka
et al., 2000; Punna et al., 2004). In a report, (Bao et al., 2009) a
highly selective demethylation/debenzylation method that was
effective in different kinds of pyrogallol trimethyl ethers using
MgI2 under solvent-free conditions have been described. In
these reactions, it was found that a variety of functional groups
were tolerated under the stated reaction conditions. Conse-
quently, this method was applied in the synthesis of biphenyls
20–36 (Table 6). Treatment of compounds 1–19 (Table 6) with
MgI2 at 80 C under solvent-free conditions gave compounds
20–36 in good to excellent yields (Scheme 8). If necessary,
the amount of MgI2 and the reaction temperature could be ad-
justed to improve the reaction yield (Bao et al., 2010) (see Ta-
bles 7–9).
3.5 The biphenyl structure is another steroidal A–C ring mi-
metic, which has been successfully used for the design of CYP
17 (P450 17) inhibitors (Zhuang et al., 2000; Wachall et al.,
1999). Consequently, the syntheses of a series of substituted
biphenyl-4-carboxylic acids designated as 5aR inhibitors have
been described. Compounds 5,9 and 11 also showed good inhi-
bition values (IC50 values of 0.64, 2.33, and 1.9 mM, respec-
tively). Contrary to the results observed for type 2 isozyme,
most of the biphenyl compounds exhibited a poor inhibitory
activity versus human type 1 isozyme. The most active com-
pound toward this enzyme was the dicyclohexyl amide 10
exhibiting 44% inhibition. Surprisingly the halogenated com-
pounds 13 and 14 did not show signiﬁcant inhibition toward
human type 1 enzyme (DU 145 cells). It is striking that the
biphenyl compounds are weak inhibitors of the human type
1 enzyme (Picard et al., 2002).26 F H F H H
27 H F F H H
28 F OMe H H H
29 F OH H H H
30 OMe H H Ac H
31 OMe H H CHOHCH3 H
32 H OH H H H
33 Me H H H H
34 H H COOH H H
35 H H CONHBu H H
36 H H CONHBn H H
R2O
R1O
OCH3
OR3
OCH3
Figure 3 Fortuneanoside E: R1 = H, R2 = Glcosyl, R3 = H
Compound I: R1 = Benzyl(Bn), R2 = H, R3 = CH3.
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Table 7 Synthetic route of synthesis 1–14 compounds.a
Compound No. Route R
1 A (CH2)2CH3
2 A (CH2)3CH3
3 A CH(CH3)2
4 A CH2CH(CH3)2
5 A Cyclohexyl
6 A CH(Cyclohexyl)2
7 B N(iPr)2
8 B N(iBu)2
9 B N(Phenyl)2
10 B N(Cyclohexyl)2
11 B NH(Adamantyl)
12 B NH(3,5-bis(triﬂuoromethyl)phenyl)
13 B Br
14 B Cl
a Synthetic procedures are described in detail in reference
Mukhopadhyay et al., 2000a,b.
Table 8 Ar and Ar0 substitutions of biphenyl-4-carboxylic
acid 5-(arylidene)-2-(aryl)-4-oxo-thiazolidin-3-yl amides.
N
H
N
O
O
H2C Ar'
Ar
Compound No. Ar Ar0
1 C6H5 C6H5
2 C6H5 3-NO2-C6H4
3 C6H5 4-Cl-C6H4
4 C6H5 3-Br-C6H4
5 C6H5 4-OCH3C6H4
6 3-Br-C6H5 C6H5
7 3-Br-C6H5 3-NO2C6H5
8 3-Br-C6H5 4-Cl-C6H4
9 3-Br-C6H5 3-Br-C6H4
10 3-Br-C6H5 4-OCH3C6H4
11 4F-C6H5 C6H5
12 4F-C6H5 3-NO2-C6H4
Table 9 R1, R2 and R3 substitutions of biphenylbenzothiaz-
ole-2-carboxamide derivatives.
S
N
N
H
R1
R2
R3
O
Compound R1 R2 R3
1 H H H
2 CH3 H H
3 H CH3 H
4 H H CH3
5 OCH3 H H
6 H H OCH3
7 H Cl H
8 H H Cl
9 H H F
10 H Cl F
11 H H Br
R1
R2
R3
R4
R5
Br
OCH3
OCH3
OCH3(HO)2B
R2
R1
R5
R4
R3
OCH3
OCH3
OCH3
R2
R1
R5
R4
R3
OCH3
H
OCH3
+ a b
Scheme 8 Synthesis of biphenyls 1–19 and 20–36. Reagents and conditions: (a) K2CO3 (2.0 equiv), Pd(OAc)2 (0.01 equiv), DMF, 110 C;
(b) MgI2 (3.0 or 6.0 equiv), 80 C.
8 Z.J. Jain et al.Two routes A and B were used for the syntheses of the
substituted biphenyl-4-carboxylic acids 1–14 (Scheme 9).
Route A is based on two successive Friedel–Crafts acylations.Please cite this article in press as: Jain, Z.J. et al., Biphenyls and t
tant aromatic structural moieties. Arabian Journal of ChemistryIn the ﬁrst one, biphenyl was reacted with the corresponding
acid chlorides to yield compounds i. Subsequent reaction with
oxalylchloride and methanol gave the corresponding meth-
oxycarbonylbiphenylketones ii from which the corresponding
carboxylic acids 1–14 were obtained by saponiﬁcation. For
route B, a Suzuki cross coupling reaction between 4-formyl-
boronic acid and the corresponding N-substituted 4-bromob-
enzamides using Pd(Ph3P)4 as catalyst14 was applied.
Compounds 13 and 14 were prepared as described (Tanaka
et al., 1998). The substituted biphenyl-4-carboxaldehydes 7–14
were subjected to a Lindgren oxidation using NaClO2 as oxida-
tive agent and 2-methyl-2-butene (Bal et al., 1981) or H2O2
(35%) (Dalcanale and Montanari, 1986) as a hypochloric acid
scavenger to yield the corresponding carboxylic acids 7–14.
Traditionally, Friedel–Crafts acylation of aromatic com-
pounds (Scheme 9, route A) is carried out with classic Lewis
acid catalysts such as AlCl3, BF3, etc. However, these acids
do not behave as true catalysts since they areconsumed in stoi-
chiometric amounts due to the formation of an adduct, and the
ensuing separation of the product by hydrolysis generates a
great deal of environmentally unfriendly waste. One of the
advantages of using zeolites as catalyst is the possibility of pro-
viding shape selectivity. Chiche et al. (1986) obtained higher p-
isomer yields when using CeNaY zeolite than with an AlCl3
catalyst. Also, Andy et al. (2000) demonstrated shape selectiv-
ity in the acylation of 2-methoxynaphthalene over Hb by
increasing the selectivity towards the 2,6-isomer by surfaceheir derivatives as synthetically and pharmacologically impor-
(2013), http://dx.doi.org/10.1016/j.arabjc.2013.07.035
R Cl
O
R
O
Cl Cl
O
O
R
O
MeOOC
Saponification
R
O
HOOC
NaClO2/H2O2
R
O
OHC
Suzuki Cross Coupling
Pd(PPh3P)4
Br
+
B(OH)2
Br
R
O
Compounds 1-14
iii
iii
Route A:
Route B:
or anhydrides
Scheme 9 Synthesis of 40-substituted biphenyl-4-carboxylic acids 1–14.
Ln(OTf)n
    CH2O, HCl
aqueous medium
+
+
Cl
Cl
Cl
Cl
Cl
Cl
BIPHENYL
(Ia) (Ib)
(IIa) (IIb)
Scheme 10 Synthetic scheme for various chloromethylated biphenyls [65].
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lites may not need such a rigid control of both the SiO2/
Al2O3 ratio of the zeolite and the operation conditions (tem-
perature and propylene pressure) in order to avoid deactiva-
tion and decrease of selectivity towards 4,40-disubstituted
product (Sugi et al., 1999). Acylation has been shown to occur
over zeolites with a wide range of reaction conditions and
SiO2/Al2O3 ratios (Harvey and Maeder, 1992). Escola1 and
Davis (2001) reported the results obtained in the acylation of
biphenyl with acetic anhydride over zeolite Hb, HY and Naf-
ion/silica as well as a study of the main variables affecting the
performance of the catalyst. In addition, the acylation of
biphenyl with both hexanoic and trimethylacetic acid have
been investigated (see Schemes 10 and 11).Please cite this article in press as: Jain, Z.J. et al., Biphenyls and t
tant aromatic structural moieties. Arabian Journal of Chemistry (3.6 The chloromethylation of biphenyl was examined with
hydrochloric acid and trioxane as formaldehyde precursor by
using some group 3 and 4 metal triﬂates as catalyst. The mix-
ture of 4-chloromethylbiphenyl (Ia), 2-chloromethylbiphenyl
(Ib), 4,40-bis(chloromethyl)biphenyl (IIa) and 2,40-bis(chloro-
methyl)biphenyl (IIb) obtained as the products. Each product
was separated by silica gel column chromatography using hex-
ane–chloroform (3/1 then 1/1) as eluent. Some group 3 and 4
metal triﬂates are highly active for the chloromethylation of
biphenyl (BP) and 9,10-dihydrophenanthrene (DHP). The
catalytic activity decreased in the order: Sc(OTf)3 >
Yb(OTf)3 > Sm(OTf) >> In(OTf)3 > Hf(OTf)4. Sc(OTf)3
had the highest activity among them. The catalysts were stable
under the reaction conditions, and catalytic amount of triﬂatesheir derivatives as synthetically and pharmacologically impor-
2013), http://dx.doi.org/10.1016/j.arabjc.2013.07.035
OHHO
Ph
1. NaOH, H2O
25oC, 20min
2. ET2SO4, 100
oC, 3h
3. aq. HCl
EtO
Ph
OH HO OEt
Ph
EtO OEt
Ph
1
1
+ + +
2a 2b 2c
2a MsCl, pyridine
25oC, 8h
HO OMs
Ph
NiCl2(PPh3)2, Zn, Et4NI
dioxane, 100oC, 24h
Ph
EtO
Ph
OEt
3
4
BBr2, CH2Cl2
25oC, 10h
Ph
HO
Ph
OH
5
Scheme 11 Synthetic route of 2,20-Diphenyl-4,40-dihydroxybiphenyl from Phenylhydroquinone. Yields: 2a = 49%, 3 = 90%, 4= 66%,
5= 91%.
N
N
R
COOH
H2N
N
N
R
COOH
O2N
EtOH
SnCl2, 2H2O
1: R=Phenyl
2: R=Ethyl
3: R=Phenyl
4: R=Ethyl
Figure 4 Chemical structure of biphenyl carboxylic benzimidazole derivatives 1,2,3 and 4.
N
H
NO2
CO2CH3
H3C
H3CO2C N
N
n-Bu
HN
N
N
N
COOH
OH
N
N
N
H
R1O2C
H3C
CO2R1
CH3
Cl
Nifedipine Losartan
n-Bu
N
N
N
H
R1O2C
H3C
CO2R1
CH3
n-BuHN
N
N
N COOH
N
1 a: R1=CH3, b: R2=C2H5
2
R1= n-Propyl, n-Butyl
R2= CH3,C2H5
N
N
H
R1O2C CO2R1
H3C CH3
3
Figure 5 Chemical structures of Nifedipine, Losartan and designed dual CCB-ARB (Compounds 1,2,3).
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C
N
H
N
O
C
H
Ar
Ar = 2-NO2C6H4, 2-ClC6H4, 3-ClC6H4, 4-ClC6H4,
         3-OCH3C6H4, 4-OCH3C6H4, 3-BrC6H4
Figure 6 Chemical structure of biphenyl-4-carboxylic acid
hydrazide-hydrazone derivatives.
N
H S
Ar
OO
Ar = C6H5-, C6H4,3-NO2C6H4, 3-OHC6H4, 4-OHC6H4, 4-FC6H4,
        2ClC6H4, 4-ClC6H4, 3-ClC6H4, 4-OCH3C6H4, 3-OCH3C6H4,
       2,3-di-OCH3C6H3, 2,4-di-ClC6H3, 2,5-di-ClC6H3
Figure 7 Chemical structure of 2-substituted-4-thiazolidinones.
Biphenyls and their derivatives as synthetically and pharmacologically important aromatic structural moieties 11was effective for the chloromethylation of BP and DHP. BP
yielded a mixture of 4-chloromethylbiphenyl (Ia), 2-chloro-
methylbiphenyl (Ib), 4,40-bis(chloromethyl)biphenyl (IIa) and
2,40-bis(chloromethyl)biphenyl (IIb). The selectivity for IIa
was around 70% among its isomers for all triﬂates (Kishida
et al., 2006).
The catalysis by triﬂates occurs in heterogeneous mixture of
hydrocarbon, trioxane and the triﬂate in aqueous hydrochloric
acid. Since the triﬂate stayed in aqueous phase during the reac-
tion, the catalyst solution was easily separated from the prod-
ucts and recycled for a new reaction. The addition of small
amount of formic acid and acetic acid enhanced the chlorom-
ethylation of Ia to increase the yield of IIa (Kishida et al.,
2006).
3.7 A new route for the synthesis of 2,20-diphenyl-4,4’-dihy-
droxybiphenyl is described. This procedure starts from com-
mercially available 2-phenol (33% overall yield) in ﬁve steps,
in which the nickel(0) catalyzed homocoupling of the aryl mes-
ylate of 4-protected-2-phenylhydroquinone was used as the
key step reaction (Bae, 1998).HN
N
N
N
N
S
O
O
N
N
N
HS
H2N
1
2
Figure 8 Chemical Structures of biphenyl tetrazole derivative 1
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derivatives
4.1. Antihypertensive activity
The renin–angiotensin system (RAS) (Quan et al., 1995) is
known to play an important role in cardiovascular regulation
(Claud et al., 1993) and the maintenance of blood pressure and
electrolyte balance. AngiotensinII (AngII) (Quan et al., 1994)
is active hormone of RAS and it mediates a variety of physio-
logical functions through stimulation of speciﬁc receptors.
There are at least two distinct receptor sub-types designed as
AT1 and AT2. The AT1 receptor mediates most of the known
AngII physiologic functions such as vasocontriction and aldo-
sterone release. The potential role for non peptide AngII recep-
tor antagonists in the treatment of hypertension has well been
demonstrated by AT1-selective AngII such as losartan.
The compounds reported in this paper, 1, 2, 3 and 4 (Fig. 4)
were the ﬁnal compounds and prepared for antihypertensive
activity. Taking Losartan as lead compound, the benzene ring
with imidazole was fused and the coupling reaction with 4-
chloromethyl biphenyl 20- carboxylic acid was carried out to
get the resulting compounds which show hypertensive activity.
At the position 2, 2-phenyl and 2- ethyl were taken. From the
study it was found that compounds that contain ethyl at posi-
tion –2 gave better result than 2-phenyl. In the biphenyl ring
carboxylic group at ortho position is necessary for pharmaco-
logical activity. At 20 position tetrazolyl moiety had the best
pharmacological activity was found in the literature. At posi-
tion 5 of benzimidazole NH2 group gives good activity (Ku-
mar et al., 2006).
4.2. Combination of antihypertensive activity and calcium
channel blocking activity (Mojarrad et al., 2011)
Angiotensin receptor blockers (ARBs) such as Losartan and
Telmisartan (Fig. 5) are potent chemicals, which antagonize
angiotensin II (Ang II) by preventing Ang II from binding to
Ang II receptor (AT1) on vascular smooth muscle. As a result,
blood vessels dilate and blood pressure is reduced. The vasodi-
latation actions of ARBs are due to reduced concentration of
intracellular Ca2+ ions (Williams and Lemke, 2002).
On the other hand, 1,4-dihydropyridines (DHP) containing
substituted heterocycles on the C4 position, such as NifedipineN
S
O
O
N
S
O
O
O N
N
R
3: R=CH3/Phenyl
; 1,3,4-triazole derivative 2 and 1,3,4-oxadiazole derivative 3.
heir derivatives as synthetically and pharmacologically impor-
2013), http://dx.doi.org/10.1016/j.arabjc.2013.07.035
Table 10 R substitutions of substituted biphenyl ethanones.
O
R
Compound No R Compound No R
a
O
i
O
H3C
H3C
b
O Br
j
O CH3
O
c
O Cl
k
O
H3C
O
d
O F
l
O
O
O
e
O NO2
m
O O
O
f
O CH3
n
O O
CH3
O
g
O
H3C
o
N
O
h
O
H3C
12 Z.J. Jain et al.(Shaﬁee et al., 1997, 2002a,b; Foroumadi et al., 2002; Hosseini
et al., 2007; Mojarrad et al., 2004, 2005), have shown to reduce
the inﬂux of extracellular Ca2+ ions through the L-type poten-
tial-dependent calcium channel therefore reducing the hyper-
tension (Williams and Lemke, 2002).
It has been hypothesized that merging the key structural
elements present in an AT1 receptor antagonists such as [2
0-
(acidic moiety)biphenyl-4-yl] imidazole pharmacophores with
key structural elements in 1,4-dihydropyridine calcium channel
blockers (CCBs) would yield compounds with potential dualPlease cite this article in press as: Jain, Z.J. et al., Biphenyls and t
tant aromatic structural moieties. Arabian Journal of Chemistryactivity for both receptors. Advantages of combination
therapy of ARBs and CCBs which include low dose, low
side effect, cardioprotection, renoprotection and anti-
atherosclerosis are reported in literatures (Hasebea and
Kikuchi; 2005; Okuda et al., 2005; Swales and Williams, 2002).
4.3. Anti inﬂammatory activity
Some new biphenyl-4-carboxylic acid 5-(arylidene)-2-(aryl)-4-
oxothiazolidin-3-yl amides have been synthesized andheir derivatives as synthetically and pharmacologically impor-
(2013), http://dx.doi.org/10.1016/j.arabjc.2013.07.035
OOH
O
O
H3C
CH3
Figure 9 Chemical structure of Biphenylindanone A (BINA).
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ylic acid hydrazide was converted to the corresponding aryl
hydrazones using aryl aldehydes in the presence of catalytic
amount of glacial acetic acid. The aryl hydrazones on reaction
with thioglycolic acid in the presence of anhydrous zinc chlo-
ride yielded the biphenyl-4-carboxylic acid 2-(aryl)-4-oxothiaz-
olidin-3-yl amides, which again on reaction with aromatic
aldehydes in the presence of anhydrous sodium acetate and
glacial acetic acid furnished the title compounds (Deep et al.,
2010a).
4.4. Diuretic activity
Diuretics are important class of drugs used in the treatment of
edema, heart failure or in hepatic, renal or pulmonary disease.
They are used, alone or in combination of antihypertensive
agents, in the treatment of high blood pressure. So there exist
urgent clinical requirements for novel, selective diuretics (high
ceiling (loop)/potassium sparing/ osmotic) devoid of many of
the unpleasant side effects viz. hypokalemia, hyperuricemia
etc. associated with current diuretic regimens. A series of N-
{(substituted)1,3-benzothiazol-2-yl}-1,1i-biphenyl-4-carbox-
amides was synthesized by reaction between biphenyl acid
chloride and 2-aminobenzothiazole (Yar and Ansari, 2009).
4.5. Anti microbial activity: biphenyl hydrazide–hydrazone
Development of novel chemotherapeutic agents is an impor-
tant and challenging task for the medicinal chemists and many
research programs are directed towards the design and synthe-
sis of new drugs for their chemotherapeutic usage. Hydrazone
compounds constitute an important class for new drug devel-
opment in order to discover an effective compound against
multidrug resistant microbial infection. Here, the synthesis ofCl Cl + m HO OH
K2CO3
NMP
CN
* O O **
CN
m
Figure 10 Polymerization of
Please cite this article in press as: Jain, Z.J. et al., Biphenyls and t
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hydrazone [Deep et al., 2010b] (see Fig. 6).4.6. Anti microbial activity: thiazolidinone
The design of novel chemotherapeutic agents is particularly
beneﬁcial due to their dissimilar mode of action which can
avoid cross resistance to known drugs. 4-thiazolidinones have
received considerable attention due to their wide range of bio-
logical activities. Some derivatives of biphenyl-4-carboxylic
acid 2-(aryl)-4-oxo-thiazolidin-3-yl–amide were synthesized
and studied for their antimicrobial activity. These compounds
were prepared from biphenyl-4-carboxylic-acid hydrazides.
Biphenyl-4-carboxylic-acid hydrazides on reﬂuxing with aryl
aldehydes in the presence of catalytic amount of glacial acetic
acid furnish the biphenyl-4-carboxylic acid hydrazone. The
aryl hydrazones on reaction with thioglycolic acid in the pres-
ence of anhydrous zinc chloride yielded the biphenyl-4-carbox-
ylic acid-2-(aryl)-4-oxo-thiazolidin-3-yl-amides (Fig. 7)
(Madhukar et al., 2009) (see Fig. 8).4.7. Anti Diabetic Activity
Non-insulin-dependent diabetes mellitus (NIDDM) is a meta-
bolic disorder characterized by hyperglycemia as well as insu-
lin resistance and/or impaired insulin secretion (De Fronzo,
1988; DeFronzo et al., 1983). Therapy for NIDDM has been
aimed at improving glycemic control by a combination of diet,
exercise, and oral agents (Gerich, 1989). These oral agents
stimulate the secretion of insulin in response to glucose and
may have extra pancreatic effects as well (Joost, 1985; Beck-
Nielsen et al., 1988).
One such strategy is to design and synthesize inhibitors for
protein tyrosine phosphatase 1B (PTP 1B), which is a legitimate
target for the treatment of Type 2 diabetes by attenuating insu-
lin resistance. PTP 1B inhibitors could potentially ameliorate
insulin resistance and normalizes plasma glucose and insulin
without inducing hypoglycemia and could be potential phar-
macological agents for the treatment of obesity and Type 2
diabetes mellitus (Non insulin dependent diabetes mellitus).
Following, is the structure of biphenyl ethanone derivatives
(Table 10) whose synthesis and structural characteristics has
been reported in reference (Sachan et al., 2009).+ (m-1)HO
,
O O *
(1-m)
PEN (BP/HQ) copolymer.
heir derivatives as synthetically and pharmacologically impor-
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14 Z.J. Jain et al.During the last few decades, considerable attention has
been devoted also to the synthesis of 1,2,4-triazole derivatives
possessing antibacterial, antifungal, anticancer and antiviral
activities (Demirba et al., 2002; El-Essawy et al., 2008). The
oxadiazole chemistry has been developed extensively. Pres-
ently, there are large number of drugs used clinically which
comprise 1,3,4-oxadiazole moiety in association with various
heterocyclic rings. Also, it has been established that coupling
of two or more biodynamic moieties results into enhanced
pharmaceutical property. In the light of these observations,
the present paper illustrates the synthesis of 1,3-thiazolidin-
2,4-dione derivatives containing biphenyl ring system
derivatised with the tetrazole (1), 1,2,4-triazoles (2), and
1,3,4- oxadiazole (3). Also, the tetrazole moiety functions as
a carboxylic acid isostere (Bradbury et al., 1993), which im-
parts greater metabolic stability and increased absorption rel-
ative to the carboxylic acid (Kamble et al., 2011).4.8. Antipsychotic and anxiolytic activity
In the present study, we describe an alternate synthesis and
further pharmacological characterization of a recently
reported positive allosteric modulator of Metabotropic
Glutamate Receptor Subtype 2 (mGluR2) termed biphenyl-
indanone A (BINA). In recombinant systems, BINA produced
a robust and selective potentiation of the response of mGluR2
to glutamate with no effect on the glutamate response of other
mGluR subtypes. In hippocampal brain slices, BINA (1 lM)
signiﬁcantly potentiated the mGluR2/3 agonist-induced inhibi-
tion of excitatory synaptic transmission at the medial perfo-
rant path-dentate gyrus synapse. BINA was also efﬁcacious
in several models predictive of antipsychotic- and anxiolytic-
like activity in mice. These results indicate that BINA is a
selective mGluR2 positive allosteric modulator and provide
further support for the growing evidence that selective alloste-
ric potentiators of mGluR2 mimic many of the in vivo actions
of mGluR2/3 agonists that may predict therapeutic utility of
these compounds. In the present study, BINA also mimicked
the effects of group II mGluR agonists and mGluR2 allosteric
potentiators in animal models used to predict potential anti-
psychotic-like and anxiolytic-like activity (Ruggero et al.,
2006) (see Fig. 9).4.9. Polymer formation
The high molecular weight biphenyl-based polyarylene ether
nitrile (PEN) copolymers were synthesized by nucleophilic sub-
stitution reaction of 2,6-dichlorobenzonitrile (DCBN) with
varying molar ratios of 4,40-dihydroxybiphenyl (BP) and
hydroquinone (HQ) (Fig. 10). The BP content of the copoly-
mers has inﬂuence on glass transition temperature (Tg), initial
decomposition temperature (Tid), mechanical properties and
the crystallinity. All the copolymers could be dissolved in
NMP (N-methyl pyrrolidone), DMF (N,N-dimethyl formam-
ide) and DMAc (Dimethyl acetate) on heating, and were stable
up to 450 C with a high char yield above 50% at 800 C in
nitrogen atmosphere. The glass transition temperature, the
melting temperature and tensile strength of copolymers were
found to increase with increase in concentration of the BP
units in the polymer (Liu et al., 2007) (see Figs. 8 and 9).Please cite this article in press as: Jain, Z.J. et al., Biphenyls and t
tant aromatic structural moieties. Arabian Journal of Chemistry4.10. Anti cancer activity
Biphenyl derivatives have also been found to show anti cancer
proﬁle (against breast cancer). Within in the literature so far, a
range of derivatives include nitro, chalcone, bis indolyl, triclo-
san, eugenol based biphenyls and the series can further be
explored.
5. Conclusion
It is concluded that biphenyls can be easily synthesized as well
as functionalized by the use of adequate catalysts such as pal-
ladium derivatives, suitable reagents and reactants such as
haloarenes. Also, the substituted biphenyls can be synthesized
by Suzuki cross coupling reactions. The substituted biphenyls
in turn can be used as an intermediate in the synthesis of phar-
macologically active molecules. Compounds containing biphe-
nyl moiety possess a wide range of activity such as
antihypertensive, antimicrobial, diuretic, anti diabetic, antipsy-
chotic and anxiolytic etc. Thus, there is a wide scope for the
synthetic scientists and chemists to synthesize more and more
compounds with different substitutions using substituted
biphenyl along with an adequate heterocycle as a basic moiety.
The investigation on this ring can still be continued and a num-
ber of such therapeutic importances of the biphenyl moiety can
be explored.Acknowledgements
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